Any carboxylic ester where the carboxylic acid component is butyric acid.
ChEBI ID: 50477
Member | Definition | Role |
---|---|---|
1-butyrylglycerol | A 1-monoglyceride resulting from the formal esterification of butyric acid with one of the primary hydroxy groups of glycerol. The R enantiomer is bioactive. | monobutyrin |
4-methylumbelliferyl butyrate | A member of the class of coumarins that is 4-methylumbelliferone in which the hydroxyl hydrogen is replaced by a butyryl group. | 4-methylumbelliferyl butyate |
4-nitrophenyl butyrate | A butyrate ester resulting from the formal condensation of the hydroxy group of 4-nitrophenol with the carboxy group of butyric acid. | p-nitrophenyl butyrate |
bucladesine | A 3',5'-cyclic purine nucleotide that is the 2'-butanoate ester and 6-N-butanoyl derivative of 3',5'-cyclic AMP. | bucladesine |
butonate | Butonate | |
difluprednate | Difluprednate | |
ethyl butyrate | A butyrate ester resulting from the formal condensation of the hydroxy group of ethanol with the carboxy group of butyric acid. | ethyl butyrate |
hydrocortisone 17-butyrate 21-propionate | Hydrocortisone butyrate propionate | |
hydrocortisone-17-butyrate | Cortisol esterified with butyric acid at the 17-hydroxy group. | cortisol 17-butyrate |
n-amyl butyrate | The butyrate ester of pentan-1-ol. | pentyl butyrate |
n-butyl n-butyrate | A butanoate ester of butan-1-ol. | butyl butanoate |
phorbol 12,13-dibutyrate | phorbol 12,13-dibutanoate | |
thapsigargin | An organic heterotricyclic compound that is a hexa-oxygenated 6,7-guaianolide isolated fron the roots of Thapsia garganica L., Apiaceae. A potent skin irritant, it is used in traditional medicine as a counter-irritant. Thapsigargin inhibits Ca(2+)-transporting ATPase mediated uptake of calcium ions into sarcoplasmic reticulum and is used in experimentation examining the impacts of increasing cytosolic calcium concentrations. | thapsigargin |
tributyrin | A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by butyric acid. | tributyrin |
tubulysin b | Tubulysin B |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 852 (9.89) | 18.7374 |
1990's | 3,581 (41.55) | 18.2507 |
2000's | 2,675 (31.04) | 29.6817 |
2010's | 1,297 (15.05) | 24.3611 |
2020's | 214 (2.48) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 70 (0.79%) | 5.53% |
Reviews | 94 (1.05%) | 6.00% |
Case Studies | 50 (0.56%) | 4.05% |
Observational | 1 (0.01%) | 0.25% |
Other | 8,699 (97.59%) | 84.16% |